What we believe
With consumers calling for more sustainable and environmental friendlier products and the industry wanting to reduce operating costs, the use of industrial biotech or white biotech has become very interesting and was thought to take over fast. However, the immatureness of some technologies, relatively low fossil fuels prices, and the effectiveness of current chemical processes have shown to be high hurdles for start-ups to take in order to penetrate the market.
At Accelerace, we remove some risks by helping you focus your time and resources on critical issues and prioritizing and de-risking your project using personalized issue trees and lean/agile business models. We provide open office hours and sparing for our founders based on over 100 years of collective entrepreneurial experience and using bespoke coaching tools & techniques built by founders for founders.
Our main focuses within biotech
Our portfolio of biotech startups
AdaptVac aims to accelerate the development of safe and efficacious therapeutic and prophylactic vaccines to treat and prevent specific cancers, infectious diseases, and immunological disorders.
Innovosens is developing a wearable device called SMASH for sports health and diabetes management. The device is the first non-invasive, multiparametric wearable sensor for continuous monitoring of glucose and lactate levels.
OSAA Innovation‘s unique invention improves patients’ quality of life by enabling them to receive IV on-the-go. The lightweight portable mechanical bag increases patients’ mobility during treatment and decreases hospitalization.
Akthelia has developed a new method for fighting infections using new compounds which act by stimulating the production of naturally occurring antimicrobial peptides (AMPs) in the body.
FRS-Systems is developing fast and reliable sensors for use in bioreactors systems. Their fluorescence dye immobilizes in a sensor spot in contact with biomass and emits red fluorescence light when exposed to blue/green light.
ImmuMap is dedicated to advancing the use and quality of flow cytometry-based monitoring of cellular immunity. They deliver cellular immunological mode-of-action analyses based on advanced flow cytometry, ELISpot, and cell culturing including unique high-end multiplex assays.
What you get
WHAT IT TAKES
A unique chance to profit from our unique network
As a part of the program you not only get the opportunity to shape your businesses in the accelerator, the most promising startups even have the chance to join the NOME network. The Nordic Mentor Network for Entrepreneurship (NOME) is a mentoring program with world-class mentors which matches Nordic projects and startups with highly skilled volunteer professionals to help them reach their goals and technology milestones.
As a part of the program, NOME also provides a unique platform for startups to participate in a boot camp in the US. There, the projects get access to FDA experts and contacts to on-site representatives. With inspiration from MIT Venture Mentoring Service, the vision of NOME is to develop and implement a best-in-class mentoring initiative that will propel the Nordic countries into one of the leading life science regions to commercialize high growth life science startups.
“The program has helped us to identify and focus on the most important thing for HelloMind at our current stage of growth. It has been extremely helpful that Accelerace has put together a diversified team of experts both inhouse and external to support us as an early-stage startup. Also, it is worth mentioning that the program is not a 'standard' program, but has been adjusted to our needs along with some added great learning seminars. We feel confident and excited.”
CEO and founder of HelloMind
At the Novo Nordisk Foundation, we are very pleased with the Nordic Mentor Network for Entrepreneurship (NOME) that Accelerace has established over the last year. Today NOME covers the entire Nordic region including life science start-ups from all Nordic countries and several high-level mentors in the network. NOME is surely on its way to become the beacon in the ecosystem that we had hoped for from the very beginning.
Head of Operations, Novo Nordisk Foundation